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Can the Ischemic Penumbra Be Identified on Noncontrast
CT of Acute Stroke?
Keith W. Muir, MD, FRCP; Jonathan Baird-Gunning, BSc; Leighton Walker, FRCR;
Tracey Baird, MRCP; Michael McCormick, MRCP; Shelagh B. Coutts, MD, FRCPC
Background and Purpose—Early ischemic changes on noncontrast CT in acute stroke include both hypoattenuation and
brain swelling, which may have different pathophysiological significance.
Methods—Noncontrast CT and CT perfusion brain scans from patients with suspected acute stroke 6 hours after
onset were reviewed. Five raters independently scored noncontrast CTs blind to clinical data using the Alberta
Stroke Program Early CT Score (ASPECTS). Each ASPECTS region was scored as hypodense or swollen. A
separate reviewer measured time to peak and cerebral blood volume in each ASPECTS region on CT perfusion.
Time to peak and cerebral blood volume were compared for each region categorized as normal, hypodense, or
isodense and swollen.
Results—Scans of 32 subjects a median 155 minutes after onset yielded 228 regions with both CT perfusion and
noncontrast CT data. Isodense swelling was associated with significantly higher cerebral blood volume (P0.016) and
with penumbral perfusion (posttest:pretest likelihood ratio 1.44 [95% CI: 0.68 to 2.90]), whereas hypodensity was
associated with more severe time to peak delay and with core perfusion (likelihood ratio 3.47 [95% CI: 1.87 to 6.34]).
Neither isodense swelling nor hypodensity was sensitive for prediction of perfusion pattern, but appearances were highly
specific (87.2% and 91.0% for penumbra and core, respectively). Intrarater agreement was good or excellent, but
interrater agreement for both hypodensity and swelling was poor.
Conclusions—Regions exhibiting hypoattenuation are likely to represent the infarct core, whereas regions that are isodense
and swollen have increased cerebral blood volume and are more likely to signify penumbral perfusion. Although
noncontrast CT is not sensitive for detection of core and penumbra, appearances are specific. Some information on tissue
viability can therefore be obtained from noncontrast CT. (Stroke. 2007;38:2485-2490.)
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Early ischemic changes (EICs) on noncontrast CT(NCCT) of the brain include changes in brain paren-
chyma that reflect either decreased attenuation (eg, loss of
definition of the lentiform nucleus) or tissue swelling (eg,
hemispheric sulcal effacement, effacement of the lateral
ventricle).1,2 Early ischemic changes are present in 60% to
80% of NCCT scans within 3 hours of middle cerebral artery
occlusion in clinical trials of thrombolysis.3–5 Systematic
approaches to recognition of EIC such as the Alberta Stroke
Program Early CT Score (ASPECTS) system improve the
detection of EIC.3–6 However, neither ASPECTS nor other
descriptive approaches distinguish clearly between hypoden-
sity (hypoattenuation) and brain swelling, which may have
different underlying pathophysiology.7
Hypodensity on NCCT is probably caused by increased
net water uptake8 and corresponds to severe ischemia that
is likely to result in infarction.9 –13 Decreased attenuation
on NCCT correlates with the apparent diffusion coefficient
value on diffusion-weighted MRI10 with the visualized
diffusion-weighted MRI lesion,14 with reduced cerebral
blood flow on positron emission tomography,9,15 and also
with reduced cerebral blood flow and cerebral blood
volume (CBV) derived from perfusion MRI.7,11 Methods
of assessing brain perfusion using contrast-enhanced CT
such as the use of CT angiography source images16,17 or
CT perfusion source images (CTP-SI)18,19 increase the
sensitivity of CT for identification of ischemic lesions and
rely on increased contrast between tissue with preserved,
and tissue with decreased, CBV. Lesions identified from
CT angiography source images correspond to those on
diffusion-weighted MRI.16
The response of metabolically active tissue to reduced
cerebral perfusion pressure is autoregulatory vasodilatation to
maintain cerebral blood flow.20,21 This results in increased
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CBV in tissue that retains metabolic capacity. Increased CBV
on MR perfusion scans acquired within a short time of NCCT
has been reported in association with regions of isodense
swelling.7,22
We sought to verify the hypothesis that hypodensity and
swelling without hypodensity on NCCT in acute stroke have
different pathophysiological significance by using CT perfu-
sion imaging.
Methods
We undertook a retrospective analysis of routinely acquired imaging
at an academic stroke center serving (for most of the study period) a
population of 180 000. Data analysis for this study was approved by
the local research ethics committee. All CT perfusion (CTP) scans
were reviewed if they were (1) conducted within 6 hours of onset of
suspected acute ischemic stroke and (2) had a concurrent NCCT
brain. During the period of data acquisition, no specific criteria were
defined for CTP request, which was at the discretion of the clinician
in charge of the case. Availability was restricted to office hours and
presence of a neuroradiologist. Most scans were requested on the
basis of clinical uncertainty about the need for treatment with
thrombolytic drugs (eg, uncertain time of onset) or uncertainty about
clinical diagnosis (eg, prior stroke and established ischemic lesions
on CT with possible new deficit).
Noncontrast CT Review
Noncontrast CT scans were blinded and randomly ordered using a
computer-generated random numbering process. A random selection
of scans was included twice among the sample to assess intrarater
agreement. The scans were provided in DICOM format to 5 CT
readers (one neuroradiologist [L.W.], 3 experienced stroke neurolo-
gists [K.M., T.B., S.C.], and one less experienced stroke physician
[M.M.]) with no clinical information, who recorded scan interpreta-
tion on a structured sheet. Reviewers were allowed to use DICOM
viewer software of their choice and were able to adjust window
settings for scans. Most were reviewed with PC-based DICOM
reading software on desktop PCs. Reviewers were asked if scans
were normal and which side was involved if abnormal. Each
reviewer then independently assessed the presence or absence of
swelling, or of hypoattenuation, of each brain region according to the
ASPECTS template. Each region could therefore be described as
normal, isodense and swollen, hypodense and swollen, or hypodense.
Intrarater agreement was determined using the repeated scans and
interrater agreement using all scans.
Regions were categorized as normal, isodense and swollen, or
hypodense if the assessments of 2 or more raters (or a majority of
raters in the event of one or more being incorrect about lesion side)
agreed on the classification.
Perfusion CT
All scans were acquired on a Philips Mx8000 using the following
parameters: 0.75-second rotation time, 120-kvP tube voltage, and
200-mAs tube current. A 50-mL bolus of iodinated contrast was
injected into an antecubital vein through a large cannula at a rate of
6 mL/sec with a scan delay of 9 seconds. A block of 45-mm slices
was obtained with a single examination. Processing was conducted
on a dedicated CT workstation using MxView 3.51 software that
calculates perfusion parameters using the maximum slope method
and gives qualitative maps of time to peak (TTP), cerebral blood
flow, and CBV. CTP data were reprocessed by one individual
(J.B.G.) without knowledge of NCCT findings. Each scan was
assessed for the slice most closely corresponding to the brain levels
used in the ASPECTS system6 and a freehand-drawn region of
interest placed within each ASPECTS-defined region (insula, cau-
date head, lentiform nucleus, internal capsule, and cortical middle
cerebral artery territories defined as M1–6) in the affected and
contralateral hemispheres (example shown in Figure 1). TTP and
CBV values were documented on a minimum of 2 separate times of
drawing each region of interest. Values were expressed relative to
the contralateral hemisphere as TTP delay (in seconds) and relative
CBV as a percentage.
Time to peak delay 3 seconds has been shown to have high
sensitivity to ischemia,23 and relative CBV of 65% to be the
optimal threshold for defining infarct core perfusion by CTP
where quantitative analysis is unavailable.24 We therefore defined
Figure 1. Example of regions of interest drawn on a the maximum intensity projection image of the perfusion CT scan with corre-
sponding CBV map and TTP and CBV measurements from each region.
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the tissue compartment of each region of interest as follows:
normally perfused tissue, TTP delay 3 seconds; penumbra, TTP
3-second delay and CBV 65%; infarct core TTP 3-second
delay and CBV 65%.
Analysis
Intra- and interrater agreement on CT region classification was
analyzed using Cohen’s kappa statistic with the Fleiss-Cuzick
extension for multirater analyses. The sensitivity, specificity, and
likelihood ratios (with 95% CIs) for posttest compared with
pretest probability of prediction of tissue compartments
were calculated.
One-way analysis of variance with post hoc pairwise comparisons
using the least significant difference method was used to compare
TTP and relative CBV across each of the 3 categories.
Results
Between September 29, 2001, and May 10, 2005, 52 patients
(of 983 total admissions) underwent NCCT and CTP exam-
inations in the department. Thirty-two fulfilled study entry
criteria and were suitable for analysis. Twenty scans were
excluded: 8 that were technically inadequate (6 attributable to
motion artifact, 2 attributable to mistiming of contrast admin-
istration), 4 undertaken in nonstroke patients (3 subarachnoid
hemorrhages and one arteriovenous malformation), 4 that did
not include the middle cerebral artery territory (brainstem or
cerebellar imaging), 2 delayed by more than 24 hours after
symptom onset, and 2 that could not be retrieved from storage
media.
The final diagnosis was ischemic stroke in 29 subjects and
nonstroke in 3 (2 functional hemipareses and one epileptic
seizure). Because all 3 nonstroke patients were imaged
acutely attributable to a clinically suspected stroke event,
their studies were included in analysis. The mean age was
6515 years (range, 26 to 86 years). There were 16 women
and 16 men. Median admission National Institutes of Health
Stroke Scale score was 11.5 (interquartile range 6 to 17).
Median onset to NCCT time was 155 minutes (interquartile
range 128.75 to 187.25 minutes), and median time between
NCCT and CTP was 10 minutes (interquartile range 6 to 18.5
minutes). Twenty-three of 32 (72%) patients were scanned
within 3 hours, and the remaining 9 between 3 and 6 hours.
Eighteen subjects (56%) received alteplase treatment.
Only 2 patients had CTP whose field of view included
both axial slices needed for ASPECTS. The remainder had
CTP whose field of view only included the lower (basal
ganglia) slice, therefore 7 of 10 ASPECTS regions. Mea-
surements could not be obtained from 2 regions attribut-
able to established infarction. Consequently, data were
available for 228 regions. On NCCT, the categorization
was 147 normal regions, 30 isodense and swollen and 51
hypodense regions. On CTP, 150 regions had normal
perfusion, 46 were penumbral, and 32 were categorized as
infarct core.
Time to peak delay differed significantly by NCCT appear-
ance category, increasing from normal to isodense swollen to
hypoattenuated brain regions (P0.001, Figure 2A).
Cerebral blood volume (expressed as relative CBV %) was
significantly higher in regions categorized as isodense and
swollen compared with either normal or hypodense regions
(overall P0.040, Figure 2B; post hoc analyses P0.016 for
normal-appearing versus isodense swelling, P0.023 for
isodense swelling versus hypodense).
There was a significant difference in the proportion of
regions with normally perfused tissue, penumbra, and core
according to the NCCT appearance (2 test for trend
P0.0001, Figure 3) with a higher probability of infarct core
perfusion pattern in hypodense tissue and higher probability
of penumbral pattern in regions that were swollen.
Sensitivities, specificities, and positive predictive values
with likelihood ratios (and 95% CIs) for the positive test
result, for NCCT appearance, and tissue compartments are
shown (Table). Isodense swelling had low sensitivity but
good specificity for penumbral perfusion. The appearance of
isodense swelling was associated with reduced likelihood of
core perfusion. Hypodensity had low sensitivity but high
specificity for core perfusion.
Overall intrarater agreement on hypodensity was good
(kappa0.659) and for swelling was moderate (kap-
pa0.515). For individual raters, kappa ranged from 0.309 to
0.827 for hypodensity and from 0.224 to 0.634 for swelling.
Figure 2. A, TTP delay and (B) CBV relative to the normal hemi-
sphere according to brain region appearance. Figures are
means; error bars represent SEs of the means. *P0.05 com-
pared with normal regions; **P0.05 compared with hypodense
regions.
Muir et al Identifying the Ischemic Penumbra 2487
 at GLASGOW UNIV LIB on January 19, 2012http://stroke.ahajournals.org/Downloaded from 
However, interrater agreement was poor for both hypodensity
(kappa0.158) and isodense swelling (kappa0.088). An
example of a CT on which there was agreement on presence
of isodense swelling is shown together with associated CTP
maps (Figure 4).
Discussion
Physiological imaging with MRI or CT (perfusion-diffusion
mismatch or CTP) to define the presence of an ischemic
penumbra allows clinicians to make acute treatment decisions
based on individual pathophysiology. Although technological
advances have presented clinicians with these data before
prospective, randomized trials can adequately test the hypoth-
eses that they generate, observational evidence suggests that
such physiological findings are relevant to the safety of, and
time window for, thrombolysis.25–28 However, because such
imaging is not routinely available in most centers worldwide,
most decisions on thrombolytic treatment continue to be
informed only by NCCT.
Anatomically extensive EIC on NCCT signifies poor
outcome and higher bleeding risk in thrombolytic trials and
prospective studies.5,6 Improved recognition of EIC over time
is evident from reanalysis of CT scans from thrombolysis
trials, all reporting a higher prevalence of EIC on detailed,
usually structured, review than in the original study groups’
estimation, eg, from 31% to 52% in the National Institute of
Neurological Disorders and Stroke, 75% to 89% in PROACT
2, and 47% to 66% in ECASS 2.3–5,29,30 The significance of
EIC in acute thrombolytic treatment decisions within 3 hours
remains the subject of debate,31,32 and there is no definitive
evidence that intravenous alteplase is ineffective or harmful
even where EIC is extensive.4 Interpretation of these trial
findings is confounded by changes in CT technology and
observer expertise over time, different trial time windows,
and subjective definition of hypodensity. Some apparently
contradictory findings such as instances of sometimes dra-
matic recovery from apparently extensive EIC3 may result
from failure to distinguish swelling from hypodensity.
Our CTP findings support previous observations derived
from combining NCCT and MR perfusion7,22 and confirm
that, within the first 6 hours after stroke onset, swelling and
hypodensity on NCCT differ in their perfusion characteristics
and therefore their underlying pathophysiology. Isodense
swelling corresponded with increased CBV and with perfu-
sion parameters of the ischemic penumbra, whereas hypoden-
sity corresponded with more severe ischemia and with infarct
core perfusion. NCCT may therefore yield evidence of tissue
viability.
There are important limitations in our study. The general-
izability of these findings is unknown; our sample included
predominantly a population with moderately severe stroke
syndromes approximately 2 to 4 hours after onset. However,
because this was a retrospective study, the population who
underwent CTP was scanned at clinical request and therefore
almost certainly represented a selected group who had a
higher probability of NCCT scans that were difficult to
interpret. In addition, there were some patients in whom the
final diagnosis was not stroke. These factors contribute to the
limited sensitivity and poor interobserver agreement that we
found and may also partly explain the unexpected finding that
in hypodense regions, mean CBV was normal rather than
reduced, as would be expected. Although specificity was high
for prediction of tissue compartments, the sensitivity of either
feature was poor, particularly for isodense swelling. Hypo-
density in particular increased the likelihood of an infarct
core perfusion pattern more than 3-fold, whereas isodense
swelling reduced the likelihood of core perfusion. The mod-
erate to excellent intraobserver agreement for both swelling
and hypodensity indicates that consistent interpretation is
possible, but the poor interrater agreement means that prior
consensus on CT definitions and training is certainly required
before these separate features could be more widely used.
Although better interobserver agreement is reported,2 agree-
ment between raters on the presence of NCCT EICs may be
limited in the absence of clinical information and our kappa
Figure 3. Proportion of regions having perfusion characteristics
of core, penumbra, and normal tissue. The absolute numbers of
regions in each category are specified in the graph.
Sensitivity, Specificity, and Likelihood Ratios With 95% CIs for Prediction of
Tissue Compartment From NCCT Appearance*
Sensitivity Specificity Overall Agreement
Likelihood Ratio
(95% CI)
Prediction of penumbra
Isodense swelling 17.4% 87.9% 73.7% (168/228) 1.44 (0.68–2.90)
Hypodensity 23.9% 78.0% 67.1% (153/228) 1.09 (0.60–1.88)
Prediction of core
Isodense swelling 9.4% 86.2% 75.4% (172/228) 0.68 (0.22–1.88)
Hypodensity 31.4% 91.0% 77.6% (177/228) 3.47 (1.87–6.34)
*Likelihood ratio expresses the ratio of posttest to pretest likelihood.
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values signifying poor interrater agreement are in line with
those reported previously, for example, in the ASPECTS
study in which neurologists blind to lateralization achieved a
kappa of 0.34 for lateralization of CT abnormalities compared
with 0.353 in our study. Knowledge of side and neurological
features improves agreement, and in addition, the varied
professional background of observers, and case selection
issues noted here, will exaggerate disagreements. The use of
small tissue volumes for perfusion measurement increases the
variability and reduces the precision of our findings.
Confirmation in a larger sample is certainly required; only
one third of regions were categorized as isodense and swollen
or hypodense. The time course and clinical (and tissue)
implications of isodense swelling on NCCT require definition
and are the subject of further study. Because we did not
routinely have follow-up NCCT, we relied on perfusion
parameters reported by other groups to be predictive of
infarct core and penumbra; although we believe the thresh-
olds we used are robust, correlation of these NCCT findings
with tissue outcome is important. If isodense swelling signi-
fies penumbra, then this appearance should be associated with
significant tissue recovery in those who reperfuse early.
Despite limitations, our findings support the hypothesis
that appearances on NCCT reflect tissue perfusion status. The
poor sensitivity and interobserver agreement of isodense
swelling are likely to limit clinical use.
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